MRK vs VTRS
By Alex · Tickerpine
Merck & Co., Inc. vs Viatris Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | VTRS |
|---|---|---|
| Price | $147.76 | $20.82 |
| Market cap | $364.26B | $23.87B |
| P/E ratio | 149.3 | — |
| ROE | 5.06% | -4.21% |
| Profit margin | 3.64% | -4.13% |
| Revenue growth | 4.70% | -0.30% |
| Dividend yield | 2.30% | 2.30% |
| Beta | 0.12 | 0.87 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs VTRS in plain English
- MRK is the bigger company — about 15.3× the market cap of VTRS.
- MRK earns a higher return on equity (5% vs -4%).
- MRK is growing revenue faster (5% vs -0%).
- VTRS has the higher dividend yield (2.30% vs 2.30%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
VTRS return calculator
See what $1,000 in Viatris Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.